Literature DB >> 18751154

Clinical Evidence: Genital herpes.

A Wald1.   

Abstract

Year:  1999        PMID: 18751154      PMCID: PMC1305690     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  32 in total

1.  A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.

Authors:  S L Spruance; S K Tyring; B DeGregorio; C Miller; K Beutner
Journal:  Arch Intern Med       Date:  1996 Aug 12-26

Review 2.  The management of herpes simplex virus infection in pregnancy.

Authors:  J R Smith; F M Cowan; P Munday
Journal:  Br J Obstet Gynaecol       Date:  1998-03

3.  A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

Authors:  S K Tyring; J M Douglas; L Corey; S L Spruance; J Esmann
Journal:  Arch Dermatol       Date:  1998-02

4.  Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.

Authors:  K H Fife; R A Barbarash; T Rudolph; B Degregorio; R Roth
Journal:  Sex Transm Dis       Date:  1997-09       Impact factor: 2.830

5.  Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.

Authors:  R Patel; N J Bodsworth; P Woolley; B Peters; G Vejlsgaard; S Saari; A Gibb; J Robinson
Journal:  Genitourin Med       Date:  1997-04

6.  The acquisition of herpes simplex virus during pregnancy.

Authors:  Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

7.  Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.

Authors:  S L Sacks; F Y Aoki; F Diaz-Mitoma; J Sellors; S D Shafran
Journal:  JAMA       Date:  1996-07-03       Impact factor: 56.272

Review 8.  Psychosocial factors and recurrent genital herpes: a review of prediction and psychiatric treatment studies.

Authors:  D Longo; K Koehn
Journal:  Int J Psychiatry Med       Date:  1993       Impact factor: 1.210

9.  Recurrence rates in genital herpes after symptomatic first-episode infection.

Authors:  J Benedetti; L Corey; R Ashley
Journal:  Ann Intern Med       Date:  1994-12-01       Impact factor: 25.391

10.  Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations.

Authors:  F M Cowan; A M Johnson; R Ashley; L Corey; A Mindel
Journal:  BMJ       Date:  1994-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.